Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?

BACKGROUND AND AIM: The impact of chronic hepatitis B virus (HBV) infection and nucleos(t)ide analogue (NUC) treatment on disease severity and clinical outcomes in patients with coronavirus 2019 (COVID-19) is unknown. The objective of this study was to determine whether HBV infection and the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Adali, Gupse, Gokcen, Pinar, Guzelbulut, Fatih, Gokcen Degirmenci Salturk, Ayca, Bugra Agaoglu, Nihat, Unal, Busra, Doganay, Levent, Ozdil, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2021
Materias:
Research Article - COVID-19 outcomes in HBV coinfection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138945/
https://www.ncbi.nlm.nih.gov/pubmed/35784904
http://dx.doi.org/10.14744/hf.2021.2021.0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138945/
https://www.ncbi.nlm.nih.gov/pubmed/35784904
http://dx.doi.org/10.14744/hf.2021.2021.0027

Ejemplares similares